|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation显示文摘 | Janssen M Frielink C Dijkgraaf I | 2004 | Cancer Biother Radiopharm2004，19，4： | 1 |
| 2 | αvβ3 Integrin-Targeting of Intraperitoneally Growing Tumours With a Radiolabeled RGD Peptide 显示文摘 | Dijkgraaf I Kruijtzer J A W Frielink C | 2006 | Int J Cancer2006，120，： | 1 |
| 3 | Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation显示文摘 | Janssen M Frielink C Dijkgraaf I | 2004 | Cancer Biother Radiophharm2004，19，4： | 1 |
| 4 | Alpha v beta 3 integrintargeting of intraperitoneally growing tumors with a radiolabeled RGD peptide显示文摘 | Dijkgraaf I Knfijtzer JA Frielink C | 2007 | Int J Cancer2007，120，3： | 1 |
| 5 | Improved tumor targetingof radiolabeled RGD peptides using rapid dose fractionation 显示文摘 | Janssen M Frielink C Dijkgraaf I | 2004 | Cancer Biother Radiopharm2004，19，4： | 1 |
| 6 | Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2 x Anfi-HSG Bispecific Antibody and a (177)Lu-Labeled Peptide 显示文摘 | van Rij CM Frielink C Goldenberg DM | 2014 | Cancer Biother Radiopharm2014，29，8： | 1 |
| 7 | Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation 显示文摘 | Janssen M Frielink C Dijkgraafn I | 2004 | Cancer Biother Radio - pharm2004，190，4： | 1 |
| 8 | Biodistribution of 131I-,186Re-,177Lu-,and 88Y-labeled hLL2(Epratuzumab) in nude mice with CD22-positive lymphoma显示文摘 | Postema EJ Frielink C Oyen WJ | 2003 | Cancer Biother Radiopharm2003，18，4： | 1 |
| 9 | Optimization of radioimmunotherapy of renal cell carcinoma:labeling of monoclonal antibody cG250 with 131I,90Y,177Lu,or 186Re显示文摘 | BROUWERS AH VAN EERD JE FRIELINK C | 2004 | Nucl Med2004，45，： | 1 |
| 10 | Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 1-131, Y-90, Lu-177, or Re-186显示文摘 | Brouwers AH van Eerd JEM Frielink C | 2004 | Journal of Nuclear Medicine2004，45，2： | 1 |
| 11 | Improved tumor targe- ting of radiolabeled RGD peptides using rapid dose fractionation 显示文摘 | Janssen M Frielink C Dijkgraaf I | 2004 | Cancer Biother Radiopharm2004，19，4： | 1 |
| 12 | Biological correlates of FDG uptake in non-small cell lung cancer显示文摘 | Lioe-Fee de Geus-Oei J. Han J.M. van Krieken Riena P. Aliredjo Paul F.M. Krabbe Cathelijne Frielink Ad F.T. Verhagen Otto C. Boerman Wim J.G. Oyen | 2006 | Lung Cancer2006，，1： | 1 |
| 13 | 显示文摘 | Michielsen M J F Frielink C Meijer E A | 1999 | Biocatal Biotransform1999，17，： | 1 |
| 14 | Biodistribution of 131I-,186Re-,177Lu-and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma显示文摘 | Postema E J Frielink C Oyen W J | 2003 | Cancer Biother Radiopharm2003，18，4： | 1 |
| 15 | Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation 显示文摘 | Janssen M Frielink C Dijkgraaf I | 2004 | Cancer Biother Radiopharm2004，19，4： | 1 |
| 16 | Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma显示文摘 | Brouwers AH Frielink C Oosterwijk E | 2003 | Cancer Biother Radiopharm2003，18，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员